BWA
ANAB icon

Basecamp Wealth Advisors’s AnaptysBio ANAB Stock Holding History

Basecamp Wealth Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6K Sell
83
-7
-8% -$424 ﹤0.01% 1148
2026
Q1 		$4.99K Sell
90
-52
-37% -$2.8K ﹤0.01% 1184
2025
Q4 		$6.88K Buy
+142
New +$5.54K ﹤0.01% 1078

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Basecamp Wealth Advisors's ANAB Position: Q2 2026 in Review

Basecamp Wealth Advisors reduced its AnaptysBio (ANAB) stake by 7.8% in Q2 2026, selling an estimated $424 and leaving 83 shares worth $5.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1148.

Basecamp Wealth Advisors first reported a position in ANAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.88K in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Basecamp Wealth Advisors held 83 shares of AnaptysBio worth $5.6K as of Q2 2026.
  • Basecamp Wealth Advisors sold 7 AnaptysBio shares in Q2 2026, an estimated $424.
  • AnaptysBio made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1148 holding.
  • Basecamp Wealth Advisors first reported a position in AnaptysBio in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's AnaptysBio position peaked at $6.88K in Q4 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.